相关实验视频

Updated: Jul 1, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

基于辅助的个性化新抗原黑色素瘤疫苗的剂量优化

Wencel Valega-Mackenzie¹, Marisabel Rodriguez Messan¹, Osman N Yogurtcu¹

¹Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.

PLoS computational biology

|March 1, 2024

概括

个性化癌症疫苗显示出希望,但最佳剂量是复杂的. 这项研究开发了一个数学模型,以优化新抗原疫苗剂量,潜在地改善瘤减少和患者的结果.

科学领域:

免疫学免疫学免疫学
计算生物学计算生物学
在瘤学瘤学.

背景情况:

下一代测序使得针对体质突变的个性化新抗原癌症疫苗成为可能.
这些疫苗利用患者的免疫系统消除癌细胞,提供临床益处.
瘤异质性在为个体患者确定最佳疫苗剂量方面具有挑战性.

研究的目的:

为个性化新抗原癌症疫苗制定数学剂量优化问题.
开发一种方法,在固定的时间表内确定最佳的疫苗剂量.
为了最大限度地降低瘤负担和同时激活T细胞的数量.

主要方法:

对疫苗诱导的免疫反应级联的数学模型进行了调整.
制定了一个剂量优化问题,以确定个性化的疫苗剂量.
在临床试验中的六名晚期黑色素瘤患者进行了in silico实验.

主要成果:

模拟比较了最佳与次优的 (临床试验) 疫苗剂量.
一种最佳的治疗方案,以更高的初始剂量和更低的最终剂量,可能会减少某些患者的瘤大小.
数学方法确定了可能改进的剂量策略.

结论:

数学剂量优化是个性化癌症疫苗治疗的一个有希望的策略.
优化剂量可能会增强瘤减少和改善临床结果.
进一步的研究可以完善这种方法,使其具有更广泛的临床应用.

更多相关视频

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.